NTRK1 and neoplasm: Interestingly, in vitro analysis of tumor cells harboring known NTRK point mutations has not shown gain-of-function to date, but instead has demonstrated impaired receptor activation and downstream signaling or no functional difference from wild-type TRK receptors11,12.